[Correspondence] Tumor Treating Fields therapy in metastatic non-small-cell lung cancer

Related Posts

• Cell surface marker-based capture of neoantigen-reactive CD8+ T-cell receptors from metastatic tumor digests

  Background Cellular immunotherapies using autologous tumor-infiltrating lymphocytes (TIL) can induce durable regression of epithelial cancers…

• [Correspondence] Combination therapies in non-clear-cell renal cell carcinoma

  We read the Article by Laurence Albiges and colleagues1 with great interest. This study provides…

• 911 Improved lifelines needed for all lines: real-world treatment patterns and attrition rates in US patients with non-driver mutation metastatic non-small cell lung cancer

  Background Immunotherapy with PD-(L)1-based strategies has rapidly transformed the treatment landscape for non-driver mutation metastatic…